Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: A prospective, randomized controlled phase III trial

Jason R. Westin, Michael A. Thompson, Vince D. Cataldo, Luis E. Fayad, Nathan Fowler, Michelle A. Fanale, Saatva Neelapu, Felipe Samaniego, Jorge Romaguera, Jatin Shah, Peter McLaughlin, Barbara Pro, Larry W. Kwak, Perpetua Sanjorjo, William A. Murphy, Camillo Jimenez, Bela Toth, Wenli Dong, Fredrick B. Hagemeister*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: A prospective, randomized controlled phase III trial'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Pharmacology, Toxicology and Pharmaceutical Science